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In  the preceding  (1)  paper we showed that  human  Ch6diak-Steinbrinck-Higashi 
syndrome  (C-HS) 1 donors  had  a  marked  impairment  in  natural-killer  (NK)-cell 
function. It was then relevant to ask whether this defect was selective for NK cells as 
previously observed in the mouse C-HS model (2) or whether other effector-cell types 
were also defective. Because the C-HS is thought to involve a single recessive gene (3), 
it was hoped that these experiments would help clarify the relationship between NK 
cells and a variety of other cell types capable of lysing tumor-cell targets, including K 
cells  involved  in  antibody-dependent  cell-mediated  cytotoxicity  (ADCC),  T  cells, 
monocytes, and neutrophils. In this paper, we show that lymphocyte-mediated ADCC 
against tumor-cell targets is also defective, whereas ADCC  mediated by both mono- 
nuclear cells and polymorphonuclear leukocytes (PMN) against erythrocyte targets is 
normal. Cytolysis of tumor cells by other effectors (T cells, monocytes, and PMN) was 
also relatively normal. These results suggest  that  C-HS patients  may have a  quite 
selective impairment in immunologic function. The implication of these findings for 
immune surveillance is discussed. 
Materials and Methods 
The  patients  and  most  of the  procedures  and  materials  used  have  been  detailed  in  the 
preceding paper (1). 
Additional  Cell Lines.  Additional cell lines used were: Daudi: human  B lymphoblastoid cell 
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I Abbreviations used in this paper: ADCC, antibody-dependent cell-mediated cytotoxicity; C-HS, Ch6diak- 
Steinbrinck-Higashi syndrome; ConA, concanavalin A; E:T, effector:target; {aH]Tdr, [aH]thymidine; LU, 
lytic units;  NK natural  killer;  PHA, phytohemagglutinin; PMN, polymorphonuclear leukocytes;  PWM, 
pokeweed mitogen; RBC, erythrocyte(s). 
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line; Chang: a cell line derived from human hepatocarcinoma; RBL-5: murine T  lymphoma 
induced by Rauscher leukemia virus; P815:  mastocytoma induced by methylcholanthrene; 
TU5:SV40 virus-transformed murine kidney cells. 
Lymphocyte Preparation.  Peripheral  blood  was  separated  by eentrifugation (1,000 g)  over 
Ficoll-Hypaque (Litton  Bionetics, Kensington, Md.)  and  the  mononuclear cell  band  was 
depleted of monocytes by adherence (45 min at 37 °) to fibronectin microexudates of detached 
TU5 kidney cells grown to confluence. Cell loss was ~20% in all donors and contamination of 
the recovered lymphocytes was <2% monocytes as judged by phagocytosis of latex beads or 
nonspecific-esterase staining and <1% PMN as indicated by Wright's-stained cytoeentrifuge 
preparations or by staining with a specific monoclonal anti-human PMN antibody generously 
provided by Dr. P. Beverley,  University College Hospital, London. 
Polymorph Preparation.  Cell pellets from Ficoll-Hypaque centrifugation were sedimented on 
dextran  followed  by  recentrifugation on  a  Ficoll-Hypaque percoll  mixture  as  previously 
described  (4). Purified  populations were  99-100%  PMN  as  indicated by  morphology and 
fluorescent staining with a monoclonal human anti-PMN antibody. 
Monocyte Preparation.  Ficoll-Hypaque-purified  mononuclear  cells were incubated on microex- 
udates of detached TU5 cells grown to confluence, and adherent cells  (4-7%  of total) were 
recovered by EDTA treatment and vigorous shaking (5, 6). Recovered cells were >90% positive 
for latex uptake and for staining with nonspecific esterase. 
ADCC.  Lymphocytes were tested in a 4-h 5aCr-release assay against NK-insensitive (RBL- 
5) and relatively low-NK-sensitive targets (Daudi and Chang), which had been pretreated  1 h 
at 20°C with a predetermined optimum concentration of antibody, and washed. RBL-5 was 
pretreated with a  1  : 10 dilution of rabbit anti-mouse thymocyte serum. Daudi, which expresses 
surface IgM, was pretreated with a  1:50 dilution of rabbit anti-human IgM (kappa) serum and 
Chang cells were pretreated with a 1:10 dilution of hyperimmune  rabbit anti-Chang cell serum. 
In some experiments, mononuclear cells and purified PMN were tested for ADCC activity in 
an 18-h assay against ~XCr-labeled  human erythroeytes pretreated with a 1/10 dilution of rabbit 
IgG anti-human erythrocyte (RBC) antibody. 
Lectin-induced Cytotoxicity.  Purified lymphocytes or PMN were tested in an 18-h 5ZCr-release 
assay against NK-insensitive  targets (P815 and RBL-5) in the presence of phytohemagglutinin 
(PHA) (PHA-P, The Welleome Research Laboratories, Beckenham, Kent, England). 
Growth-mhibiton Assay (Cytostasis).  Target cells were plated at a concentration of 2 ×  104/ 
sample and incubated with varying numbers of PMN. After 24 h at 37°C, cultures were pulsed 
with  1 #Ci of [3H]thymidine ([3H]Tdr)  for  12  h  and then harvested on a  Mash  harvester, 
(Microbiological Associates,  Walkersville, Md.) and counted in a Packard liquid scintillation 
counter (Packard Instrument, Inc., Downers Grove, Ill.). The percentage inhibition  of [3H]Tdr 
uptake was calculated according to the formula (1 -  A/B) ×  100, where A was the radioactivity 
incorporated in the presence of effector  cells, and B was the isotope uptake in control cultures 
without effectors. Granulocytes took up <5% of the isotope and the inhibition  of isotope uptake 
was not a result of cold thymidine release  (4). 
Cytolytic Assays.  Cytolysis in short-term (<24 h)  assays was measured by 5XCr release  from 
labeled targets as described previously in detail (2). The percent lysis was calculated as: 
test counts per minute -  autolysis 
percent lysis = 
total counts per minute 
where the autolysis of targets was measured in the absence of effectors and the total counts per 
minute were measured in an aliquot of labeled targets. Cytolysis in long-term (48 h) assays was 
measured by [aH]Tdr release from target cells prelabeled 18-24 h with [3H]methyl thymidine. 
The percent lysis was calculated as A/B ×  100, where A was the counts per minute in the test 
sample and B was the sodium dodecyl sulfate-releasable radioactivity. Autolysis by target cells 
alone (always <33%) was subtracted from this value. 
Results 
Deficient ADCC  in  CoilS Donors against  Tumor  Targets.  As shown in Fig.  1  (upper 
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Fro.  1.  ADCC against tumor cell targets. Peripheral blood mononuclear cells, depleted of mono- 
cytes on microexudates, were tested for ADCC against Daudi, Chang, and RBL-5 cells that were 
pretreated  with  rabbit  antibody  against  human  IgM (kappa), Chang,  and  mouse thymocytes, 
respectively, in a 5-h 51Cr-release assay at  varying effector:target (E:T)  ratios. Values represent 
mean percent lysis of triplicate wells + SE against antibody-treated targets before (upper panels) or 
after (lower panels) subtraction of the percent lysis for non-antibody-treated  targets. Autolysis of 
antibody-treated targets alone was 7.1, 8.5, and 18.9% for Daudi, Chang, and RBL-5, respectively. 
Subjects: (0) J. R. (normal); (O) J. O. (normal); ([7) La. R. (C-HS) (ix) Le. R. (C-HS). 
donors were  markedly  impaired  in  their  capacity  to lyse three  antibody  precoated 
tumor-cell lines.  Because there was some lysis of non-antibody-coated targets as well, 
as a  result  of NK effects, the lytic values  for antibody-coated  and  uncoated  targets 
have been subtracted  (Fig.  1, lower panel)  to give values reflecting only ADCC.  In 
the representative  experiment  shown,  the two normal subjects  had a  mean  value of 
170 lytic units (LU)/106 against Daudi and  125 LU/106 against Chang, compared to 
10 LU/106 and 4  LU/106, respectively, for the C-HS donors when calculated  at  the 
20%  lysis  level.  This  reflects  an  average 24-fold  deficiency  in  ADCC  lytic capacity 
against human tumor cells by C-HS lymphocytes. 
Lysis  of antibody-coated  RBL-5,  a  murine  tumor,  was  also  impaired  in  C-HS 
donors although for unknown reasons, the impairment was less pronounced than that 
seen against human tumors (Fig.  1, right panel). The difference between normal (131 
LU/10  ~) and C-HS lymphocytes (16 LU/106) was only eight fold, based on LU. These 
ADCC experiments were repeated on three separate occasions with two C-HS patients, 
and  similar  results  were  obtained  with.six  different  age-  and  sex-matched  normal 
donors. 
Fractionation  procedures  revealed  that  the  effector cells  mediating  ADCC  were 
nonadherent  lymphocytes with receptors for the Fc portion of IgG (FcR  +)  (Table I). 
In addition,  removal  of adherent  cells without  receptors  for the  Fc portion  of IgG 
(FcR-) did not restore the C-HS ADCC response beyond a normal enrichment effect. 1052  NATURAL-KILLER-CELL IMMUNODEFICIENCY 
TABLE  I 
Fractionation of ADCC Effector Cells 
Experiment  Fractionation  Normal (J. G.)  C-HS (Le. R.) 
LU/IOS§ 
Unpassed*  97 (59)  <1  (10) 
Sephadex G-10 passed  133 (63)  4 (15) 
FcR-:~  ND II  (o)  ND (0) 
FcR+  ND  (22)  ND (2) 
* Peripheral  blood  mononuclear cells  were passed  through  Sephadex  G-10 
columns and  compared  in  a  4-h SnCr-release assay  at  various E:T ratios 
against  Daudi target cells that were precoated with rabbit anti-human IgM 
(kappa). 
:~ Peripheral blood mononuclear cells were depleted of monocytes by adherence 
to  plastic  and  then  incubated  on  immune-complex-coated plastic  dishes. 
Nonadberent  lymphocytes  (FcR-)  were  recovered  in  the  supernate  and 
adherent  (FcR  +) cells were eluted with EDTA and scraping.  Both fractions 
were incubated overnight and then assayed  for 4 h against  RBL-5 targets 
that were precoated with rabbit antl-thymocyte serum. 
§ Calculated at  15% lysis, and the numbers in brackets represent the percent 
lysis at a 50:1 E:T ratio. 
[[ ND, not done. 
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FIG,  2.  ADCC against erythrocyte targets.  Mononuclear cells (74% lymphocytes and 23% mono- 
cytes)  were obtained by Ficoll-Hypaque separation,  and  the lymphocytes consisted  of -72%  E- 
rosette-forming cells (T cells), 10% surface-Ig-positive  cells (B cells), and 27% FoR  ÷ cells (IgG) with 
no significant differences between donors.  PMN were obtained by dextran sedimentation of Ficoll- 
Hypaque pellets and consisted of ~80% FcR  ÷ cells, 90% of which phagocytosed bovine erythrocytes 
5n,  coated with rabbit  anti-bovine RBC antibody  (IgG).  Effector cells were tested  in an  18-h  Cr- 
release  assay  against  human  RBC  (type A  ÷)  precoated with a  1/10 dilution of rabbit  IgG anti- 
human RBC antibody. Subjects:  (&) normal  1; (,)  normal 2; (A) La. R. (C-HS); (I-1) I,e. R. (C- 
US). 
Therefore, the defect in ADCC  by C-HS  cells is not likely a  result of suppressor  cells. 
Normal ADCC against RBC Targets in C-HS Donors.  The  results  in  Fig.  2  show that 
the failure of lymphocytes to efficiently lyse tumor cells (Fig.  1)  was not a  result  of a 
generalized  block  in  the  ADCC  mechanism  because  mononuclear  effector cells and 
PMN  from C-HS donors lysed antibody-coated human  RBC erythrocytes in a  normal 
fashion. 
Spontaneous Lysis by Monocytes and Cytostasis by PMN are Normal in C-HS Donors.  As 
shown  in  Table  II  monocytes,  purified  on  the  basis  of adherence  to  microexudates, 
caused  low but significant  lysis of [aH]Tdr-labeled  tumor  cells (TU5)  when  tested  in 
a  48-h  assay.  Levels  of lysis  were  not  different  in  the  two  normal  and  two  C-HS KLEIN ET AL.  1053 
Donors 
TABLE  II 
Spontaneous Lysis of Tumor Cells by Monocytes 
Percent lysis 
20:1  E:T ratio  10:1 E:T ratio 
j. G. (normal)  15.0  12.4 
j.j. (normal)  ND*  13.6 
La. R. (C-HS)  ND  12.8 
Le. R. (C-HS)  13.0  ND 
Ficoll-Hypaque-pufified  mononuelear  cells were  incubated on  microexu- 
dates, and adherent  cells (4-7%) were recovered by EDTA treatment and 
vigorous shaking.  Effectors (>90% latex positive, and nonspecific esterase 
positive) were tested in a 48-h [aH]Tdr-release assay against TU5 target cells 
(SV40 virus-transformed mouse kidney cells). 
* ND, not done. 
TABLE  III 
Spontaneous Cytostusis of Tumor Cells by PMN Leukocytes 
Donor 
Percent cytostasis 
20:1 E:T ratio  10:1 E:T ratio 
J. o. (normal)  33  ND* 
J. G. (normal)  32  9 
J.J. (normal)  39  20 
La. R. (C-HS)  26  19 
Le. R. (C-HS)  33  18 
Cell pellets from  Ficoll-Hypaque  were sedimented  on dextran  followed by 
recentrifugation on a Ficoll-Hypaque-pereoll mixture (4). Purified populations 
were 99% PMN as indicated by morphology and staining with monoclonal 
anti-human PMN antibody. Effectors were tested in a 36-h cytostasis assay as 
measured  by inhibition of [3H]Tdr uptake during a  12-h pulse. Cytostasis 
against K562 was not inhibited by catalase (4). 
patients tested. PMN, purified from peripheral blood by dextran sedimentation, were 
also tested for cytostasis of K562 target cells. As shown in Table III levels of cytostasis 
were not different between the C-HS donors and normals. 
Lectin-induced Killer Cells.  Lectin-dependent cytolysis of tumor cells by peripheral 
blood lymphoeytes has been shown  to be mediated largely by T  cells (7) of both T# 
and Ty types (8)  and is thought  to reflect the cytolytic potential of the total T  cell 
pool  (9).  As  shown  in  Fig.  3,  PHA-dependent  lysis of both  P815  and  RBL-5  was 
entirely  normal  in  one  C-HS  donor  (Le.  R.)  but  was  low  in  the  other  (La.  R.), 
compared to four age- and sex-matched normal donors. The dose of PHA used was 
optimum and all donors had a  similar threshold for stimulation (Fig. 4). 
Neutrophils are also capable of lysing certain tumor cells in the presence of lectin 
(10).  As shown  in Table IV, lysis of RBL-5 by purified PMN  from C-HS donors in 
the presence of PHA was within the normal range. 
Mitogen-induced Proliferation.  As shown in Fig. 5, [aH]Tdr uptake in C-HS lympho- 
cytes was normal in response to the T-dependent lectins, concanavalin A  (ConA) and 
PHA and the B- and T-dependent  lectin pokeweed mitogen (PWM)  in confirmation 
of earlier reports (11). The magnitude of the peak response, the mitogen threshold for 1054  NATURAL-KILLER-CELL IMMUNODEFICIENCY 
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Fio.  3.  Lectin-dependent cytolysis by lymphocytes.  Lymphocytes were depleted of monocytes on 
microexudates and were tested in an  18-h ~lCr-release assay against  P815 (mouse mastocytoma) or 
RBL-5 (Rausher leukemia virus-induced murine lymphoma) targets in the presence  of 2.0 p.g/ml 
PHA. No lysis occurred in the absence of PHA, and these concentrations were not toxic. Cytolysis 
was  not apparent  at  4  h  of incubation.  Values represent  mean  percent  lysis in  triplicate wells. 
Standard error values were <10% of the mean. Subjects:  (0) J. J., (A) j. G., (I) B. S., and (I-7) G. 
B., all normal; (A) Le. R. and (C)) La. R., both C-HS. 
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Fro.  4.  Lectin titration in lectin-dependent cytolysis. Peripheral blood lymphocytes were tested in 
an  18-h 51Cr-release assay  against  P815  targets  at  a  25:1 E:T ratio  in  the presence  of varying 
concentrations  of PHA.  Values  represent  mean  percent  lysis of triplicate wells.  Standard  error 
Values were <10% of the mean. Subjects:  (0) G. B. ahd (A) B. S., normal; (C)) Le. R. and (•)  L.R., 
C-HS; (F-I) autolysis  in the presence of PHA. 
a  detectable  response,  and  the  optimum  mitogen  dose  was  similar  in  C-HS  and 
normal donors, thereby suggesting normal B  and T  cell response to mitogenic stimuli. 
Discussion 
These  results  suggest  that  the  C-HS  defect  in  cellular cytotoxicity  is  selective for 
effector lymphocytes  mediating ADCC  against  tumor  cells. 
In the preceding  paper  (1),  we showed  that  NK  cytolysis wa  s  impaired  :>400-fold 
in terms of LU compared  to a  24-fold defect  in ADCC  as shown  here  (Fig.  1).  These 
findings  suggest  that  some,  but  not  necessarily  all,  lymphocyte  ADCC  activity  is 
mediated  by  NK  cells.  This  hypothesis  is supported  by  the  work  of others  (12)  who 
find striking parallels  in  NK  and  ADCC: activity in the human  (12).  For example  in KLEIN  ET AL. 
TABLE  IV 
Lectin-dependent cytolysis by PMN Leukocytes 
Donor 
Percent lysis 
5: I E:T  1  : 1 E:T 
j.j.  (normal)  60  33 
J. G. (normal)  25  18 
La. R. (C-HS)  50  26 
Le. R. (C-HS)  51  22 
Peripheral-blood PMN leukocytes  (99% pure) were tested in an  18-h cytolytic 
assay against RBL-5 in the presence of 6 #g/ml PHA. No lysis occurred in the 
absence of PHA or in shorter assay-incubation periods such as 4 h. 
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FIG.  5.  Peripheral blood mononuclear cells, depleted of monocytes on microexudate plates,  were 
assayed for mitogen-induced proliferation in the presence of varying concentrations of PHA, ConA, 
or PWM. Cells were in culture for a total of 4 d and were pulsed with [SH]Tdr ~30 h before harvest. 
Values represent  mean counts per minute ±  SD of triplicate wells. Control values in unstimulated 
wells were ~ 1,000 ±  100 cpm for subjects J. R., J. O., and Le. R., whereas La. R. yielded a value 
of 14,845 ± 655 cpm. Subjects:  (O) J. R. and (0) J. O., normals; ~  La. R.; and (Ira) Le. R., C-HS. 
our  study,  both  NK  (1)  and  ADCC  (Table  I)  effectors  were  FcR +,  nonadherent 
lymphocytes.  In additional  experiments,  removal of FcR-  cells or adherent  cells did 
not  restore  the  ADCC  defect  in  cells  from  C-HS  donors,  thereby  suggesting  that 
adherent  suppressor  cells, such  as those described  by Cudkowicz and  Hockman  (13), 
were not solely responsible for the C-HS  defect.  Furthermore,  the defective ADCC  of 
tumor-cell  targets  did  not  reflect  a  generalized  failure  in  the  ADCC  mechanism 
because  ADCC  against  antibody-coated  human  RBC  mediated  by  PMN  or mono- 
nuclear  cells  was  normal  (Fig.  2).  As  shown  by  others,  ADCC  against  RBC  by  a 1056  NATURAL-KILLER-CELL IMMUNODEFICIENCY 
mononuclear fraction is largely mediated by monocytes (14). Further experiments also 
revealed that  the defect in  NK-lymphocyte-mediated lysis shown  in  the preceding 
paper (1) was not a result of a generalized failure of the spontaneous lytic mechanism 
because purified monocytes from C-HS donors lysed tumor targets in a normal fashion 
(Table II). In addition, PMN from C-HS donors exhibited normal growth inhibitor 
effects when assayed against  K562, an NK-sensitive target. Cytostasis in this system 
was previously shown to be catalase insensitive (4). These findings, together with the 
observation  of  normal  PMN-mediated,  lectin-dependent  cytolysis  of tumor  cells 
(Table  IV)  by C-HS  donors  are  surprising  because  the  principal  defect  in  C-HS 
patients recognized to date has been a morphological and functional abnormality of 
granules in their granule-containing cells, most readily recognizable in the PMN  (3, 
15).  This  suggests  that  the  enzymes  that  are  deficient  in  C-HS  granules  such  as 
elastase (16) may not be important in PMN-mediated cytolysis or cytostasis. It is also 
interesting to note that it is the primary or azurophil granules which are defective in 
C-HS granulocytes (15). Because ConA induces the release of cytolytic extracellular 
enzymes from azurophil  granules  (10), as well  as  specific granules,  (17)  in  normal 
cells, our results showing normal lectin-dependent cytolysis by PMN further suggest 
that these enzymes (myeloperoxidase) are excreted normally in spite of the abnormal 
structure of azurophil granules. In addition, metabolic H202 must also be generated 
normally in C-HS PMN because this agent is necessary for lectin-induced cytolysis by 
PMN (10). 
T  cell-effector function in purified lymphocyte populations was indirectly assessed 
by lectin-dependent cytolytic assays that have been shown to solely measure cytotoxic 
T  cells in the human  (7, 8). One C-HS patient  (Le. R.)  responded normally to two 
different, NK-insensitive  targets,  whereas  the other patient  (La.  R.)  was  deficient. 
Therefore a  definitive statement on the status  of cytolytic T  cells in  these patients 
awaits a larger study. However, T  cell-mediated immunity in general was previously 
shown to be normal in these and other patients as judged by delayed hypersensitivity 
to mumps, candida, dinitrochlorobenzene, and streptokinase-streptodornase, and by 
proliferative responses to T-dependent mitogens, ([11, 18,  19]; Fig. 5). In addition, T 
cell immunity in beige mice, the animal model for the C-HS syndrome, was relatively 
normal  with  respect  to rejection of skin  grafts,  lectin-dependent T  cell killers, and 
alloimmune or mixed-lymphocyte-culture-generated cytotoxic lymphocytes (2). 
In summary, these results show that the cytolytic defect in C-HS donors is selective 
for NK-ADCC  ceils and  does not  appear to involve other effector cell types. This 
implies that the lytic mechanisms involved in NK and ADCC are distinct from those 
mediated  by other effector cells  (T cells,  monocytes, and  PMN).  The existence of 
patients  with  such  a  selective effector-cell defect  affords  a  unique  opportunity  to 
delineate the actual steps involved in  the lytic pathway utilized by NK or K  cells. 
Furthermore the occurrence of this selective immunological defect in C-HS patients, 
who are known to have a high incidence of lymphoproliferative disease (20), suggests 
that  NK-ADCC cells may play an important  role in immune surveillance in man. 2 
Summary 
Antibody-dependent  cell-mediated  cytolysis  (ADCC)  of human  tumor  cells  by 
2 Since submission of the manuscript, we have been able to completely restore the defective NK response 
in  C-HS  patients  by  a  short  preincubation  of  PBL  with  cyclic  guanosine  monophosphate (P.  Katz, 
Unpublished result.'). KLEIN ET AL.  1057 
FcR  ÷  nonadherent  effector lymphocytes as well  as natural  killer  (NK)  activity was 
markedly impaired in Ch6diak-Steinbrinck-Higashi Syndrome (C-HS) patients. Com- 
pared  to  a  >400-fold  defect  in  NK  activity  in  terms  of lytic  units,  the  abnormal 
ADCC response in C-HS donors was 24-fold below normal suggesting a  partial  but 
not complete overlap of lymphocytes or lytic mechanisms responsible for ADCC and 
NK.  The  ADCC  mechanism  against  erythrocyte  targets,  however,  was  normal, 
thereby  suggesting  a  qualitative  difference  in  these  two  forms  of ADCC.  Other 
effector-cell  functions  against  tumor-cell  targets  were  normal  as  measured  by  (a) 
spontaneous cytolysis mediated by monocytes, (b) spontaneous cytostasis mediated by 
neutrophils, and (c) lectin-dependent cytolysis mediated by neutrophils. Although one 
C-HS  patient  was  low  in  lectin-dependent  cytolysis mediated  by lymphocytes,  the 
other C-HS patient was normal, thereby suggesting that cytolytic T  function was not 
linked to the NK-ADCC defect. In addition, the proliferative response to T-dependent 
mitogens  was  also  relatively  normal.  These  results,  combined  with  other  studies 
showing normal cell-mediated and humoral immunity in these same patients, suggest 
that  patients  with  C-HS have an  immunodeficiency which  is  selective  for NK and 
ADCC activity. 
Received for publication  10 December 1979. 
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